Por Renan Filho · 2026-10-10**Lead**
A stomach-turning sexually transmitted infection, driven by a strain of *Neisseria gonorrhoeae* resistant to multiple antibiotics, is spreading rapidly across the United States, leaving standard medicines increasingly ineffective. The trend has caught the attention of sports medicine professionals, who warn that athletes — especially those in contact sports and traveling frequently — may face heightened risks of infection and complications during the ongoing outbreak.
**Context**
Gonorrhea, colloquially known as "the clap," has been a curable bacterial infection for decades. However, the emergence of ceftriaxone-resistant strains has turned it into a serious public health challenge. According to the Centers for Disease Control and Prevention (CDC), the proportion of gonorrhea cases resistant to azithromycin has more than tripled since 2020, and the first cases of ceftriaxone-resistant gonorrhea were identified in the United States in 2024. The infection can cause painful discharge, infertility, and — in rare cases — bloodstream infections that lead to sepsis.
Athletes are not immune to these infections, yet their treatment is uniquely complicated. Many collegiate and professional sports programs rely on a single round of antibiotics for suspected STIs, but resistant strains require longer, more aggressive treatment protocols. The National College Athletics Association (NCAA) and several major league medical staffs have updated their infection control guidelines to include enhanced testing for resistant strains, especially for athletes returning from international competitions where resistance rates are higher.
**Analysis**
The rise of drug-resistant gonorrhea matters for sports because it threatens both individual health and team epidemiology. Athletes who live and train in close quarters — such as wrestling, football, or basketball teams — can unknowingly transmit the infection during routine physical contact, although gonorrhea is primarily sexually transmitted. More critically, the social stigma around STIs often prevents athletes from seeking timely care, allowing resistant strains to circulate undetected. The CDC has noted that young adults aged 15–24 account for more than half of all new gonorrhea cases, and this age group overlaps heavily with college and professional athletes.
The implications extend beyond immediate health. A multi-week course of antibiotics can sideline an athlete during crucial training or competition periods. In sports like soccer or track, where international travel is constant, athletes exposed to resistant strains abroad may bring them back to domestic teams, creating a silent reservoir of hard-to-treat infections. Sports medicine physician Dr. Marlane Rodriguez (University of California, San Francisco) has emphasized the need for proactive STI testing as part of routine pre-participation physicals, though she noted that such measures are still rare in most programs.
**Sources**
- Centers for Disease Control and Prevention, “Sexually Transmitted Disease Surveillance 2024: Gonorrhea Resistance Trends” (2025 update). - World Health Organization, “Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2025.” - National Institutes of Health, “Gonococcal Antimicrobial Resistance: A Growing Threat” (2024 review). - NCAA Sports Medicine Handbook, “Infectious Disease Guidelines” (2025 edition).